Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016

Date: December 30, 2016
Pages: 57
Price:
US$ 1,500.00 US$ 1,275.00
Offer valid until September 1, 2017!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: K22938E6CAFEN
Leaflet:

Download PDF Leaflet

Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016

SUMMARY

Global Markets Direct’s, ‘Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Kissei Pharmaceutical Co Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Kissei Pharmaceutical Co Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

SCOPE
  • The report provides a snapshot of the pipeline therapeutic landscape of Kissei Pharmaceutical Co Ltd
  • The report provides overview of Kissei Pharmaceutical Co Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Kissei Pharmaceutical Co Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Kissei Pharmaceutical Co Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
REASONS TO BUY
  • Evaluate Kissei Pharmaceutical Co Ltd’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Kissei Pharmaceutical Co Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Kissei Pharmaceutical Co Ltd’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Introduction
Global Markets Direct Report Coverage
Kissei Pharmaceutical Co Ltd Snapshot
Kissei Pharmaceutical Co Ltd Overview
Key Facts
Kissei Pharmaceutical Co Ltd - Research and Development Overview
Key Therapeutic Areas
Kissei Pharmaceutical Co Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Kissei Pharmaceutical Co Ltd - Pipeline Products Glance
Kissei Pharmaceutical Co Ltd - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Kissei Pharmaceutical Co Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Kissei Pharmaceutical Co Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Kissei Pharmaceutical Co Ltd - Drug Profiles
AS-192426900 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AS-192781900 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AS-193280400 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
bedoradrine sulfate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KDT-3594 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KLH-2109 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KSI-6666 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KTA-439 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mitiglinide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ozagrel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
remogliflozin etabonate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
rovatirelin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit SGLT1 for Postprandial Hyperglycemia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YS-110 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Kissei Pharmaceutical Co Ltd - Pipeline Analysis
Kissei Pharmaceutical Co Ltd - Pipeline Products by Target
Kissei Pharmaceutical Co Ltd - Pipeline Products by Route of Administration
Kissei Pharmaceutical Co Ltd - Pipeline Products by Molecule Type
Kissei Pharmaceutical Co Ltd - Pipeline Products by Mechanism of Action
Kissei Pharmaceutical Co Ltd - Dormant Projects
Kissei Pharmaceutical Co Ltd - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
diquafosol tetrasodium
KEA-0477
KGA-3235
KLS-0611
KUX-1151
neflamapimod
remogliflozin etabonate
ritobegron
sergliflozin
Kissei Pharmaceutical Co Ltd - Company Statement
Kissei Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Kissei Pharmaceutical Co Ltd, Key Facts
Kissei Pharmaceutical Co Ltd - Pipeline by Indication, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Stage of Development, 2016
Kissei Pharmaceutical Co Ltd - Monotherapy Products in Pipeline, 2016
Kissei Pharmaceutical Co Ltd - Partnered Products in Pipeline, 2016
Kissei Pharmaceutical Co Ltd - Partnered Products/ Combination Treatment Modalities, 2016
Kissei Pharmaceutical Co Ltd - Out-Licensed Products in Pipeline, 2016
Kissei Pharmaceutical Co Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2016
Kissei Pharmaceutical Co Ltd - Pre-Registration, 2016
Kissei Pharmaceutical Co Ltd - Phase III, 2016
Kissei Pharmaceutical Co Ltd - Phase II, 2016
Kissei Pharmaceutical Co Ltd - Phase I, 2016
Kissei Pharmaceutical Co Ltd - Preclinical, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Target, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Route of Administration, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Molecule Type, 2016
Kissei Pharmaceutical Co Ltd - Pipeline Products by Mechanism of Action, 2016
Kissei Pharmaceutical Co Ltd - Dormant Developmental Projects,2016
Kissei Pharmaceutical Co Ltd - Discontinued Pipeline Products, 2016
Kissei Pharmaceutical Co Ltd, Other Locations
Kissei Pharmaceutical Co Ltd, Subsidiaries

LIST OF FIGURES

Kissei Pharmaceutical Co Ltd - Pipeline by Top 10 Indication, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Stage of Development, 2016
Kissei Pharmaceutical Co Ltd - Monotherapy Products in Pipeline, 2016
Kissei Pharmaceutical Co Ltd - Partnered Products in Pipeline, 2016
Kissei Pharmaceutical Co Ltd - Out-Licensed Products in Pipeline, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Top 10 Target, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Route of Administration, 2016
Kissei Pharmaceutical Co Ltd - Pipeline by Molecule Type, 2016
Kissei Pharmaceutical Co Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016
Skip to top


Ask Your Question

Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: